Albumin and Furosemide in Nephrotic Syndrome
Phase 2
Recruiting
- Conditions
- ephrotic syndrome.Nephrotic syndrome
- Registration Number
- IRCT20120415009475N11
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 128
Inclusion Criteria
??Age between 2 to 15 years
Diagnosis of Nephrotic Syndrome
Exclusion Criteria
Allergy to Albumin
Allergy to Furosemide
Urine output less than 0.5 ml/kg/hr
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient weight. Timepoint: 24 hours after intervention. Method of measurement: Weighing the patient.;Urine sodium level. Timepoint: 24 hours after intervention. Method of measurement: urine analysis.
- Secondary Outcome Measures
Name Time Method